Lung cancer showdown: surgery or radiation – which is better?
NCT ID NCT05183932
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 446 people with stage I non-small cell lung cancer who chose either surgery or stereotactic body radiation therapy (SBRT). Researchers will track cancer recurrence, survival, and quality of life for up to 3 years to see which treatment offers better outcomes. The goal is to provide clearer guidance for patients and doctors facing this decision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors and patients choose between surgery and radiation for early-stage lung cancer based on real-world outcomes.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient selection. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carle Cancer Institute
Urbana, Illinois, 61801, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Toronto
Toronto, Ontario, Canada
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a radioactive tracer reveal whether immunotherapy is working?
- Can a new nucleotide analogue boost cancer treatment?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can standard cancer treatment wake up the immune system? a study investigates.